Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
- PMID: 30688118
- PMCID: PMC6352954
- DOI: 10.1080/14756366.2018.1532418
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
Abstract
Fatty Acid Amide Hydrolase (FAAH) is a serine hydrolase that plays a key role in controlling endogenous levels of endocannabinoids. FAAH inhibition is considered a powerful approach to enhance the endocannabinoid signalling, and therefore it has been largely studied as a potential target for the treatment of neurological disorders such as anxiety or depression, or of inflammatory processes. We present two novel series of amide derivatives of ibuprofen designed as analogues of our reference FAAH inhibitor Ibu-AM5 to further explore its structure-activity relationships. In the new amides, the 2-methylpyridine moiety of Ibu-AM5 was substituted by benzylamino and piperazinoaryl moieties. The obtained benzylamides and piperazinoarylamides showed FAAH inhibition ranging from the low to high micromolar potency. The binding of the new amides in the active site of FAAH, estimated using the induced fit protocol, indicated arylpiperazinoamides binding the ACB channel and the cytosolic port, and benzylamides binding the ACB channel.
Keywords: FAAH inhibition; Ibuprofen amides; endocannabinoids; fatty acid amide hydrolase; induced fit docking.
Figures






Similar articles
-
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.J Enzyme Inhib Med Chem. 2020 Dec;35(1):815-823. doi: 10.1080/14756366.2020.1743283. J Enzyme Inhib Med Chem. 2020. PMID: 32200655 Free PMC article.
-
Novel propanamides as fatty acid amide hydrolase inhibitors.Eur J Med Chem. 2017 Aug 18;136:523-542. doi: 10.1016/j.ejmech.2017.05.033. Epub 2017 May 12. Eur J Med Chem. 2017. PMID: 28535469
-
Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).Bioorg Med Chem. 2014 Dec 1;22(23):6694-6705. doi: 10.1016/j.bmc.2014.09.012. Epub 2014 Sep 16. Bioorg Med Chem. 2014. PMID: 25282655
-
Computational insights into function and inhibition of fatty acid amide hydrolase.Eur J Med Chem. 2015 Feb 16;91:15-26. doi: 10.1016/j.ejmech.2014.09.037. Epub 2014 Sep 16. Eur J Med Chem. 2015. PMID: 25240419 Review.
-
Application of computational methods to the design of fatty acid amide hydrolase (FAAH) inhibitors based on a carbamic template structure.Adv Protein Chem Struct Biol. 2011;85:1-26. doi: 10.1016/B978-0-12-386485-7.00001-6. Adv Protein Chem Struct Biol. 2011. PMID: 21920320 Review.
Cited by
-
Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents.J Enzyme Inhib Med Chem. 2021 Dec;36(1):940-953. doi: 10.1080/14756366.2021.1875459. J Enzyme Inhib Med Chem. 2021. PMID: 33896320 Free PMC article.
-
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.J Enzyme Inhib Med Chem. 2020 Dec;35(1):815-823. doi: 10.1080/14756366.2020.1743283. J Enzyme Inhib Med Chem. 2020. PMID: 32200655 Free PMC article.
-
Renal Outcomes and Other Adverse Effects of Cannabinoid Supplementation.Nutrients. 2024 Dec 27;17(1):59. doi: 10.3390/nu17010059. Nutrients. 2024. PMID: 39796493 Free PMC article. Review.
-
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition.Int J Mol Sci. 2022 Dec 7;23(24):15502. doi: 10.3390/ijms232415502. Int J Mol Sci. 2022. PMID: 36555144 Free PMC article.
References
-
- Di Marzo V. New approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov 2018;17:623–39. - PubMed
-
- Palermo G, Rothlisberger U, Cavalli A, De Vivo M. Computational insights into function and inhibition of fatty acid amide hydrolase. Eur J Med Chem 2015;91:15–26. - PubMed
-
- Bracey M, Hanson M, Masuda K, et al. . Structural adaptions in a membrane enzyme that terminates endocannabinoid signaling. Science 2002;298:1793–6. - PubMed
-
- McKinney MK, Cravatt BF. Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 2005;74:411–32. - PubMed
-
- Tuo W, Leleu-Chavain N, Spencer J, et al. . Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and n-acylethanolamine acid amidase inhibitors. J Med Chem 2017;60:4–46. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources